Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Tickers DXCM RHHBY SRPT
Tags SRPT Recent Press Releases Market News
From Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
Tickers CLRB HARP LMDX RHHBY
Tags Market News RHHBY LMDX
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
Tickers ASML RHHBY TEAM
Tags TEAM Recent Press Releases ASML
From Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Tickers LMDX NEWS RHHBF RHHBY
Tags Benzinga General RHHBY
From Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
Tickers AZN LLY NVO PFE
Tags Market News RHHBY AZN
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags News Health Care CALT
From Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Tickers NVDA RHHBY
Tags NVDA Recent Press Releases RHHBY
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Tickers IPO IPOS NVO RHHBY
Tags Biotech RHHBY IPOs
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags Stocks to Buy NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY Market News
From InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Tickers PSTX RHHBF RHHBY RHHVF
Tags News Trading Ideas Penny Stocks
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
Tickers NVO RHHBY VKTX
Tags Recent Press Releases VKTX RHHBY
From Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
Tickers ALT AZN LLY NVO
Tags PFE LLY ALT
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags RHHBY Biotech General
From Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Tickers ALT MYNZ PFE RHHBY
Tags ALT Benzinga contributors
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
Tickers RHHBF RHHBY RHHVF
Tags General News Large Cap
From Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags wegovy Jim Cramer Roche Holding
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags RHHBY Biotech General
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
Tickers ABSI AZN NVDA RHHBY
Tags General Contracts Media
From Benzinga
Ignore Crypto: These Stocks Could Make You Rich
Tickers MDT NEE RHHBY
Tags RHHBY NEE MDT
From Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Tickers CLDX LUNG PSTX RHHBY
Tags LUNG Stocks to Buy CLDX
From InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
Tickers AZN BMY MRK RHHBY
Tags News Large Cap Health Care
From Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
Tickers BIIB LLY RHHBY
Tags RHHBY Market News LLY
From Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
Tickers REGN RHHBY
Tags Briefs Movers Market News
From Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
Tickers RHHBF RHHBY RHHVF SRPT
Tags News Health Care RHHVF
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Tickers BHC CAH CVS NVS
Tags Healthcare Sector RHHBY Benzinga
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Tickers LLY PFE RHHBY
Tags LLY Recent Press Releases Market News
From Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Tickers PFE RHHBY ROIV XBI
Tags Market News RHHBY Recent Press Releases
From Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
Tickers PFE RHHBY ROIV
Tags ROIV Today's Market PFE
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
Tickers PFE RHHBF RHHBY ROIV
Tags Markets RHHBF Asset Sales
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
Tickers PFE RHHBY ROIV
Tags ROIV RHHBY PFE
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.